Skip to main content

Applied Imaging, US Food and Drug Administration, Vysis

Premium

Applied Imaging has received 510(k) clearance from the US Food and Drug Administration to market its Ariol Her-2/neu FISH application, which is designed to detect Her-2/neu gene amplification in breast cancer biopsy samples using fluorescence in situ hybridization, the company said.

The application is the final addition to the breast cancer panel on the Ariol system which also includes assays for Her-2/neu immunohistochemistry, Her-2/neu FISH, estrogen receptor, and progesterone receptor.

The Ariol Her-2/neu FISH application uses the PathVysion Her-2/neu DNA Probe Kit from Vysis, a subsidiary of Abbott Labs.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.